Analyst Recommendations for Boston Scientific and Peers in June
Of the 24 analysts covering Boston Scientific in June, 19 of them have given the stock a “buy” or higher rating. Five of them have given it a “hold.” The mean rating for the stock is 1.67 with a target price of $32.76. In June, 16 of the 20 analysts covering Abbott Laboratories (ABT) gave the stock a “buy” or higher rating.